1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Purity >98.0% (HPLC) Brexpiprazole Intermediate Factory

Whakaahuatanga Poto:

1-(1-Benzothiophen-4-yl)piperazine Hydrochloride

CAS: 913614-18-3

Maamaa: >99.0% (HPLC)

Te ahua: Ma ki te Paura-White

Takawaenga o Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Nga Ahuatanga matū:

Ingoa matū 1-(1-Benzothiophen-4-yl)piperazine Hydrochloride
Nga kupu taurite Brexpiprazole Intermediate 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Tau CAS 913614-18-3
Tau CAT RF-PI1034
Tūnga Taonga I roto i te Raarangi, Te Whakaputa Whakanui 100MT / Tau
Tātai rāpoi C12H15ClN2S
Taumaha rāpoi 254.7789
Waitohu Ruifu Chemical

Whakatakotoranga:

Tūemi Whakatakotoranga
Te ahua Ma ki te Paura-White
Tautuhinga Ko te wa pupuri o te tauira ka rite ki tera o te paerewa tohutoro
Te Maama / Tikanga Tatauria >99.0% (HPLC)
Ngaronga i te whakamaroke <0.50%
Wai (KF) <0.50%
Te toenga i runga i te mura <0.20%
Nga Taonga Paanga (HPLC)
Te poke takitahi <0.50%
Nga poke katoa <1.00%
Spectrum Infrared He rite ki te Hanganga
Proton NMR Spectrum He rite ki te Hanganga
Paerewa Whakamatau Paerewa hinonga
Whakamahinga Takawaenga o Brexpiprazole (CAS: 913611-97-9)

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku

Painga:

1

FAQ:

Taupānga:

Ko te 1-(1-Benzothiophen-4-yl)piperazine Hydrochloride (CAS: 913614-18-3) he takawaenga o Brexpiprazole (CAS: 913611-97-9).Ko te Brexpiprazole he momo antipsychotic atypical.Ko te dopamine D2 kaiawhina agonist waahanga.Hei tauira mo te rerotonin-dopamine mahi modulator, ka taea te whakamahi mo te maimoatanga o te schizophrenia, mo te maimoatanga taapiri mo te pouri.Ka taea hoki te whakarato i te whaihua me te ngawari ki runga i nga maimoatanga taapiri kua whakaritea mo te mate pouri nui (MDD).Ko te tarukino e whakaatu ana i tetahi tohu rongoora ahurei, e mahi ana hei agonist wahanga o te serotonin 5-HT1A me te dopamine D2 receptors me te rite ki te tino antagonist o 5-HT2A me te noradrenaline α1B/2C receptors, he rite te hononga here subnanomolar.Ko te tarukino, i whakawhanakehia e Otsuka me Lundbeck, i whakaaetia i te 2015 e te FDA mo te maimoatanga o te schizophrenia me te maimoatanga taapiri mo te pouri.

Tuhia to korero ki konei ka tukuna mai ki a matou